VEGFA and cancer: Therefore, it was suggested that a combination of current anti-angiogenic therapies, such as anti-VEGF treatment, and metabolic targeting may have a higher therapeutic efficacy and specificity in human patients with cancer than current anti-angiogenic therapies.